MeiraGTx Holdings plc (MGTX)

Etorro trading 970x250
MeiraGTx Holdings plc (MGTX) Logo

About MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients living with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson’s diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson’s program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren’s syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company’s proprietary riboswitch technology. The company was incorporated in 2015 and is based in New York, New York. Address: 430 East 29th Street, New York, NY, United States, 10016

MeiraGTx Holdings plc News and around…

Latest news about MeiraGTx Holdings plc (MGTX) common stock and company :

MeiraGTx to Provide a Xerostomia Clinical Program Update and Host a Virtual Research and Development Day on Gene Regulation
29 Nov, 2021 Yahoo! Finance

LONDON and NEW YORK, Nov. 29, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage gene therapy company, today announced it will host a conference call and webcast to provide an update on the Company’s AAV-hAQP1 Phase 1 AQUAx clinical trial for the treatment of radiation-induced xerostomia (RIX) on Tuesday, December 7, 2021, at 8:00 a.m. ET. MeiraGTx will also host a virtual R&D Day via webcast and conference call that will be held on Wednesday,

Looking for Growth in Small and Mid Cap Life Science Stocks
15 Nov, 2021 FinancialContent

2021 is an unusual year for biotech with a “blow-off” February high in speculative small caps.

MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates
10 Nov, 2021 Yahoo! Finance

MeiraGTx Holdings PLC (MGTX) delivered earnings and revenue surprises of -13.46% and 38.94%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

MeiraGTx Reports Third Quarter 2021 Financial and Operational Results
10 Nov, 2021 Yahoo! Finance

LONDON and NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results for the third quarter ended September 30, 2021 and provided an update on recent progress. During the quarter, MeiraGTx continued to progress the Phase 3 Lumeos Trial of botaretigene sparoparvovec, formerly referred to as AAV5-RPGR, in X-linked retinitis pigmentosa (XLRP) with its partner Janssen Pharmaceutical

MeiraGTx to Participate in Upcoming Virtual Investor Conferences
09 Nov, 2021 Yahoo! Finance

LONDON and NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., President and Chief Executive Officer, will participate in the following virtual investor conferences: Barclays Gene Editing & Gene Therapy Summit Corporate presentation: Monday, November 15, 2021, at 2:00 p.m. ET 33rd Annual Piper Sandler Healthcare Conference Fireside chat: available from Monday

MeiraGTx Holdings (NASDAQ:MGTX) Is In A Good Position To Deliver On Growth Plans
08 Nov, 2021 Yahoo! Finance

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

12 Health Care Stocks Moving In Monday's After-Market Session
01 Nov, 2021 FinancialContent

Gainers Biophytis (NASDAQ:BPTS) shares moved upwards by 37.54% to $8.5 during Monday's after-market session. The market value of ...

Earnings Preview: MeiraGTx Holdings PLC (MGTX) Q3 Earnings Expected to Decline
28 Oct, 2021 Yahoo! Finance

MeiraGTx Holdings PLC (MGTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MeiraGTx Announces the Presentation of Two Novel Inherited Retinal Disease (IRD) Programs and Riboswitch Gene Regulation Platform at the European Society of Gene and Cell Therapy (ESGCT) 2021 Annual Congress
19 Oct, 2021 Yahoo! Finance

Three Poster Presentations Highlight Versatility and Novelty of MeiraGTx’s Gene Therapy Development Platforms Novel Synthetic Riboswitch Platform Reversibly Regulates Gene Expression to High Dynamic Range and Drives Precise Dose Responsive Activation of Transgene Expression In Vivo LONDON and NEW YORK, Oct. 19, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced three poster presentations at the European Soc

46 Biggest Movers From Yesterday
19 Oct, 2021 FinancialContent

Gainers Valneva SE (NASDAQ: VALN) shares surged 39.8% to close at $39.21 on Monday after the company reported VLA2001 met both ...

Notable Monday Option Activity: CRTX, CPLG, MGTX
18 Oct, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Cortexyme Inc (CRTX), where a total of 24,490 contracts have traded so far, representing approximately 2.4 million underlying shares. That amounts to about 960.3% of CRTX's average daily trading volume over the past month of 255,020 shares..

12 Health Care Stocks Moving In Monday's Intraday Session
18 Oct, 2021 FinancialContent

Gainers Progenity (NASDAQ:PROG) shares increased by 33.17% to $2.85 during Monday's regular session. As of 12:30 ...

34 Stocks Moving In Monday's Mid-Day Session
18 Oct, 2021 FinancialContent

Gainers Valneva SE (NASDAQ: VALN) shares jumped 34.6% to $37.75 after the company reported VLA2001 met both co-primary endpoints ...

12 Health Care Stocks Moving In Monday's Pre-Market Session
18 Oct, 2021 FinancialContent

Gainers Valneva (NASDAQ:VALN) stock increased by 35.65% to $38.05 during Monday's pre-market session. The market ...

Barron's Latest Picks And Pans: Amazon, Apple, Chevron, Citigroup, Dell And More
16 Oct, 2021 FinancialContent

This weekend's Barron's cover story features the latest results of the annual Barron's Big Money Poll. Other ...

This Small Biotech Is Partnering With Johnson & Johnson. The Stock Could More Than Double.
16 Oct, 2021 Yahoo! Finance

MeiraGtx is quietly working on a promising new approach to gene therapy. Sizing up the opportunity, pondering the unknowns.

Sum Up The Pieces: VTWV Could Be Worth $168
08 Oct, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Russell 2000 Value ETF (VTWV), we found that the implied analyst target price for the ETF based upon its underlying holdings is $167.98 per unit.

MeiraGTx Holdings plc (MGTX) Fell Out Of Favor With Hedge Funds
04 Oct, 2021 Yahoo! Finance

The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which unveil their equity positions as of June 30th. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund portfolios. Our extensive […]

MeiraGTx to Present at the Chardan 5th Annual Genetic Medicines Conference
28 Sep, 2021 FinancialContent
5 Gene Therapy Stocks Back in Focus on AbbVie/Regenxbio Deal
14 Sep, 2021 FinancialContent

Gene therapy is set to become one of the most vital spaces with high prospects in the biotech sector.

MeiraGTx Announces Data at EURETINA 2021 Virtual Meeting Demonstrating Reversal of Disease Progression Following Treatment with AAV5-RPGR in X-Linked Retinitis Pigmentosa
09 Sep, 2021 FinancialContent
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
09 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Analysts Expect IBBQ Will Reach $32
07 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Nasdaq Biotechnology ETF (IBBQ), we found that the implied analyst target price for the ETF based upon its underlying holdings is $32.44 per unit.

My 2019 Report Card: Up 319%
15 Aug, 2021 FinancialContent

I made 63 bullish calls involving 45 companies in 2019. Here are the winners, the stinkers, and everything in between.

Analysts' Revenue Estimates For MeiraGTx Holdings plc (NASDAQ:MGTX) Are Surging Higher
12 Aug, 2021 Yahoo! Finance

Shareholders in MeiraGTx Holdings plc ( NASDAQ:MGTX ) may be thrilled to learn that the analysts have just delivered a...

MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Tops Revenue Estimates
11 Aug, 2021 Yahoo! Finance

MeiraGTx Holdings PLC (MGTX) delivered earnings and revenue surprises of 13.21% and 13.69%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

MeiraGTx Reports Second Quarter 2021 Financial and Operational Results
11 Aug, 2021 FinancialContent
Do Insiders Own Lots Of Shares In MeiraGTx Holdings plc (NASDAQ:MGTX)?
09 Aug, 2021 Yahoo! Finance

The big shareholder groups in MeiraGTx Holdings plc ( NASDAQ:MGTX ) have power over the company. Large companies...

How The Pieces Add Up: IWN Targets $189
04 Aug, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Russell 2000 Value ETF (IWN), we found that the implied analyst target price for the ETF based upon its underlying holdings is $188.56 per unit.

MeiraGTx Holdings PLC (MGTX) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
29 Jul, 2021 Yahoo! Finance

MeiraGTx Holdings PLC (MGTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MeiraGTx Holdings plc (MGTX) is a NASDAQ Common Stock listed in , ,

970x250